- Home
- GBR vs ACON Comparison
GBR vs ACON Comparison
Compare GBR & ACON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GBR | ACON |
|---|---|---|
| Founded | 1978 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Retail: Computer Software & Peripheral Equipment |
| Sector | Energy | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.3M | 4.4M |
| IPO Year | N/A | 2022 |
Fundamental Metrics
Financial Performance| Metric | GBR | ACON |
|---|---|---|
| Price | $0.79 | $6.16 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $23.00 |
| AVG Volume (30 Days) | 25.5K | ★ 79.0K |
| Earning Date | 11-12-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $153,000.00 | $67,483.00 |
| Revenue This Year | N/A | $145.39 |
| Revenue Next Year | N/A | $145.45 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 4.08 | ★ 36.91 |
| 52 Week Low | $0.67 | $5.55 |
| 52 Week High | $1.78 | $3,499.49 |
Technical Indicators
Market Signals| Indicator | GBR | ACON |
|---|---|---|
| Relative Strength Index (RSI) | 47.64 | 46.26 |
| Support Level | $0.75 | $5.81 |
| Resistance Level | $0.88 | $6.37 |
| Average True Range (ATR) | 0.05 | 0.64 |
| MACD | 0.01 | 0.03 |
| Stochastic Oscillator | 33.18 | 18.91 |
Price Performance
Historical ComparisonAbout GBR New Concept Energy Inc
New Concept Energy Inc is a United States-based company engaged in Real Estate Operations. It intends to continue to operate and or sell its West Virginia property. It provides advisory and management services for an independent West Virginia oil and gas company. The Company seeks to establish or acquire new business operations. It operates in one segment, which is real estate rental.
About ACON Aclarion Inc.
Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. Its product Nociscan is a SaaS platform that leverages MR Spectroscopy to noninvasively help physicians distinguish between painful and nonpainful discs in the spine. The company derives its revenues from one source, the delivery of Nociscan reports to medical professionals. Substantially all revenues are generated from contracts with customers in the United States.